Related Experiment Videos
Immunohistochemical analysis for histopathological subtypes in pediatric medulloblastomas
Eun-Ik Son1, Il-Man Kim, Dong-Won Kim
1Department of Neurosurgery, Institute for Medical Science, Keimyung University School of Medicine, Deagu, Korea.
Pathology International
|February 18, 2003
Summary
Immunohistochemical markers aid in classifying pediatric medulloblastomas. Anaplastic subtypes showed higher Ki-67 proliferation than non-anaplastic types, with specific markers differentiating tumor subclasses.
Area of Science:
- Pediatric Oncology
- Neuro-oncology
- Pathology
Background:
- Medulloblastomas in children exhibit diverse histological features, including varying degrees of anaplasia and nodularity.
- Accurate subclassification of medulloblastomas is crucial for prognosis and treatment planning.
Purpose of the Study:
- To evaluate the utility of immunohistochemical markers in subclassifying pediatric medulloblastomas.
- To identify specific markers that can differentiate between anaplastic and non-anaplastic subtypes.
Main Methods:
- Immunohistochemistry was performed on 17 pediatric medulloblastoma samples representing different histological subtypes.
- Expression of neural cell adhesion molecule (NCAM), nerve growth factor receptor (NGFR), neurofilament (NF), synaptophysin (SYN), glial fibrillary acidic protein (GFAP), S100, Bcl-2, and Ki-67 was analyzed.
Main Results:
- NGFR, NF, GFAP, and S100 were absent in anaplastic medulloblastomas but present in nodules of non-anaplastic subtypes.
- All tumors expressed NCAM, SYN, and Bcl-2.
- Anaplastic subtypes exhibited significantly higher Ki-67 labeling indices (39.0%) compared to non-anaplastic subtypes (11.4%).
Conclusions:
- Immunohistochemical markers are valuable tools for characterizing pediatric medulloblastoma subtypes.
- Distinct marker expression patterns can help differentiate between anaplastic and non-anaplastic medulloblastomas.